Ludger Staib

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

Claus Rödel, Ullrich Graeven, Rainer Fietkau et al. · The Lancet Oncology · 2015 · 713 citations

Final Results, Radiation Medicine, Radiation Therapy +9

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

Claus Rödel, Torsten Liersch, Heinz Becker et al. · The Lancet Oncology · 2012 · 694 citations

Surgical Oncology, Radiation Therapy, Gastrointestinal Oncology +8

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

Emmanouil Fokas, Michael Allgäuer, Bülent Polat et al. · Journal of Clinical Oncology · 2019 · 505 citations · Full text

Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Emmanouil Fokas, Anke Schlenska‐Lange, Bülent Polat et al. · JAMA Oncology · 2021 · 324 citations · Full text

FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies.

C. G. Diederichs, Ludger Staib, Gerhard Glatting et al. · PubMed · 1998 · 201 citations